chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 55.0
Sex: M
Vaccine: HEP
Symptoms: Convulsion, Hypokinesia, Injection site erythema, Injection site pain, Pain
Clinical narrative: RECEIVED IMMUNIZATION 1 SHOT OF 3 YESTERDAY.  WITH IN 8 HOURS SITE OF INJECTION BECAME EXTREMELY SORE AND PAINFUL, COMPLETE RIGHT ARM WAS INVOLVED AND COULD NOT BE MOVED WITHOUT SEVERE PAIN.  I HAVE NEVER FELT PAIN LIKE THIS.  SLEEP WAS IMPOSSIBLE AND WIFE SAID THAT A SEIZURE HAPPENED, WHILE I WAS SLEEPING, WHICH SHE WOKE ME FROM AND FROM THAT POINT AROUND 2200 HRS - 2300 HRS THIS DATE, HAD SEVERE PAIN AND HAD TO SUPPORT ONE ARM WITH THE OTHER.  ALL MOVEMENT CAUSED SEVERE PAIN.  SITE OF INJECTION WAS NOT THAT RED.
Age: 2.0
Sex: M
Vaccine: DTAP, HBHEPB, IPV, MMR, VARCEL
Symptoms: Back pain, Hypokinesia, Musculoskeletal stiffness, Oedema peripheral, Pyrexia
Clinical narrative: FATHER STATES THAT SON HAD SWELLING IN BOTH LEGS FROM HIPS TO KNEES AND COULD NOT WALK.  HE ALSO STATES THAT SON HAD PAIN AND STIFFNESS IN LOWER BACK, AND A 100.1 TEMP APPROXIMATELY 3 HOURS AFTER RECEIVING HIS IMMUNIZATIONS ON 7/13/2005.  HE DID NOT CALL DR. (SON'S PEDIATRICIAN) UNTIL TODAY (7/14/2005) AFTER HE SPOKE TO ME AT THE CITY HEALTH DEPARTMENT. HE INFORMED ME THAT HE MASSAGED HIS SON (STATING THAT HE IS A MASSAGE THERAPIST) AND WAS ABLE TO GET THE SWELLING DOWN AND THE PAIN TO SUBSIDE.  I ASKED IF HE HAD GIVEN SON TYLENOL AS WE INSTRUCTED THE MOTHER TO DO (SHE BROUGHT SON IN FOR SHOTS), BUT FATHER STATED THAT HE WAS NOT TOLD BY MOTHER THAT HE NEEDED TO DO THAT .
Age: 0.3
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Fontanelle bulging, Irritability, Pyrexia
Clinical narrative: Patient received Pediarix on 07/13/2005. Baby became febrile during the night as high as 104 degrees.  He became extremely irritable and had bulging fontanel by AM 07/14/2005.  Baby examined at office and sent immediately to Emergency Room for LP tap.  No signs of meningitis. Baby continues to be monitored.
Age: 1.3
Sex: F
Vaccine: DTAP, HIBV, PNC
Symptoms: Vomiting
Clinical narrative: VOMITING X SEVERAL HOURS THE NIGHT AFTER SHOTS WERE GIVEN THAT SAME DAY.  SELF RESOLVED BY NEXT MORNING
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Discomfort, Feeling hot, Injection site erythema, Injection site swelling
Clinical narrative: Left upper arm (deltoid) slight swelling, erythema, warm to touch. To use Tylenol for discomfort
Age: 1.0
Sex: F
Vaccine: DPP, MMR, PPV
Symptoms: Irritability, Pyrexia, Rash
Clinical narrative: High fever(104.00), heavy rash, fussiness.
Age: 25.0
Sex: F
Vaccine: YF
Symptoms: Bacterial infection, Blood bilirubin increased, Blood creatinine increased, Blood urea increased, Chills
Clinical narrative: From initial information received on 10Jun04 from regarding an adverse event occurring, it was reported that a 25 year old female pt who was born, at age 15, received her first dose  of YF Vax on 26Apr04 and her first dose of hep A vaccine (manf not reported) on 21Apr04 in preparation for a trip. The lot numbers routes and sites of admin were not reported. On 26Apr04, approx ten hours after receiving the YF Vax, the pt reported that she had yellow eyes and a fever of 102.4 F. She saw a medical doctor on 27Apr04, who did labs and found that the pt had jaundice, fever, chills, myalgia and a headache. She had a bilirubin of 2.5 and WBC of 13.2, neutrophils, absolute of 11, 603 (normal range is 1500-7800) and lymphocytes, absolute of 766 (normal range is 850-3900). AST and ALT were normal. A blood culture had no growth. Her urine had a trace of ketones, 1+ leukocyte esterase and a few bacteria. Her urine culture had no growth. Her urine had a trace of ketones, 1+ leukocytes esterase and a few bacteria. Her urine culture had 50,000 to 100, 000 CFU/ml lactobacillus and may represent normal flora contamination. Follow up on 06May04 was normal and follow up total bilirubin on 06May04 was 0.5. The pt reported the fever lasted several days and went down after antipyretics. The pt gradually recovered over the next few days. From additional information received on 17Jun04, additional physician information and laboratory results were provided. It was also reported that the YF Vax lot number was UE128AA (admin SC) and the Hep A vaccine lot number was 0860N (admin IM). The pt has recovered from these events. No further information is anticipated, this case is considered closed.
Age: 25.0
Sex: F
Vaccine: YF
Symptoms: Headache, Jaundice, Laboratory test abnormal, Myalgia, Pyrexia
Clinical narrative: From initial information received on 10Jun04 from regarding an adverse event occurring, it was reported that a 25 year old female pt who was born, at age 15, received her first dose  of YF Vax on 26Apr04 and her first dose of hep A vaccine (manf not reported) on 21Apr04 in preparation for a trip. The lot numbers routes and sites of admin were not reported. On 26Apr04, approx ten hours after receiving the YF Vax, the pt reported that she had yellow eyes and a fever of 102.4 F. She saw a medical doctor on 27Apr04, who did labs and found that the pt had jaundice, fever, chills, myalgia and a headache. She had a bilirubin of 2.5 and WBC of 13.2, neutrophils, absolute of 11, 603 (normal range is 1500-7800) and lymphocytes, absolute of 766 (normal range is 850-3900). AST and ALT were normal. A blood culture had no growth. Her urine had a trace of ketones, 1+ leukocyte esterase and a few bacteria. Her urine culture had no growth. Her urine had a trace of ketones, 1+ leukocytes esterase and a few bacteria. Her urine culture had 50,000 to 100, 000 CFU/ml lactobacillus and may represent normal flora contamination. Follow up on 06May04 was normal and follow up total bilirubin on 06May04 was 0.5. The pt reported the fever lasted several days and went down after antipyretics. The pt gradually recovered over the next few days. From additional information received on 17Jun04, additional physician information and laboratory results were provided. It was also reported that the YF Vax lot number was UE128AA (admin SC) and the Hep A vaccine lot number was 0860N (admin IM). The pt has recovered from these events. No further information is anticipated, this case is considered closed.
Age: 25.0
Sex: F
Vaccine: YF
Symptoms: White blood cell disorder
Clinical narrative: From initial information received on 10Jun04 from regarding an adverse event occurring, it was reported that a 25 year old female pt who was born, at age 15, received her first dose  of YF Vax on 26Apr04 and her first dose of hep A vaccine (manf not reported) on 21Apr04 in preparation for a trip. The lot numbers routes and sites of admin were not reported. On 26Apr04, approx ten hours after receiving the YF Vax, the pt reported that she had yellow eyes and a fever of 102.4 F. She saw a medical doctor on 27Apr04, who did labs and found that the pt had jaundice, fever, chills, myalgia and a headache. She had a bilirubin of 2.5 and WBC of 13.2, neutrophils, absolute of 11, 603 (normal range is 1500-7800) and lymphocytes, absolute of 766 (normal range is 850-3900). AST and ALT were normal. A blood culture had no growth. Her urine had a trace of ketones, 1+ leukocyte esterase and a few bacteria. Her urine culture had no growth. Her urine had a trace of ketones, 1+ leukocytes esterase and a few bacteria. Her urine culture had 50,000 to 100, 000 CFU/ml lactobacillus and may represent normal flora contamination. Follow up on 06May04 was normal and follow up total bilirubin on 06May04 was 0.5. The pt reported the fever lasted several days and went down after antipyretics. The pt gradually recovered over the next few days. From additional information received on 17Jun04, additional physician information and laboratory results were provided. It was also reported that the YF Vax lot number was UE128AA (admin SC) and the Hep A vaccine lot number was 0860N (admin IM). The pt has recovered from these events. No further information is anticipated, this case is considered closed.
Age: 48.0
Sex: M
Vaccine: HEPAB, TYP, YF, HEPAB, TYP, YF
Symptoms: Abdominal discomfort, Diarrhoea, Headache, Hepatic enzyme abnormal, Malaise
Clinical narrative: This case was received and there were no serious criteria reported. Based upon appropriate medical judgement, this case is considered non-serious. From initial info received on 6/10/04, through an enhanced surveilance program regarding an adverse event occurring in an unknown country, it was reported that a 48 year old male pt received a dose of Yellow Fever vaccine, a dose of Typhoid vaccine and a dose of Twinrix, on 4/6/04. The lot numbers, routes and sites of administration were not reported. Three days later, the pt developed aches and malaise. Approximately 1 week after immunizations, he also developed fevers up to 102F. The pt saw his physician on 4/16/04 for evaluation of headaches, fever and diarrhea. The pt's recovery status was not reported. From additional info received on 6/17/05, it was reported through an enhanced surveilance program , it was reported that this case occurred in the USA. Reportedly, the pt received his 1st dose of YF-VAX, lot UE126AA, SC in the right arm; a dose of Typhim VI, lot X0481, IM in the left deltoid and his 1st dose of Twinrix, lot AHABA026AA, IM in the right deltoid on 4/6/04 between one and four in the afternoon. Three days later, on 4/9/04, he developed generalized aches and malaise. Seven days after vaccination, he experienced a fever up to 102F. He was seen by a physician on 4/16/04 for a fever of 101.2F, headache, upset stomach and diarrhea. He was dx'd with serum sickness. Reportedly, the pt recovered from this experience. Further info is not anticipated, this case is considered closed.
Age: 48.0
Sex: M
Vaccine: HEPAB, TYP, YF, HEPAB, TYP, YF
Symptoms: Myalgia, Pyrexia, Serum sickness
Clinical narrative: This case was received and there were no serious criteria reported. Based upon appropriate medical judgement, this case is considered non-serious. From initial info received on 6/10/04, through an enhanced surveilance program regarding an adverse event occurring in an unknown country, it was reported that a 48 year old male pt received a dose of Yellow Fever vaccine, a dose of Typhoid vaccine and a dose of Twinrix, on 4/6/04. The lot numbers, routes and sites of administration were not reported. Three days later, the pt developed aches and malaise. Approximately 1 week after immunizations, he also developed fevers up to 102F. The pt saw his physician on 4/16/04 for evaluation of headaches, fever and diarrhea. The pt's recovery status was not reported. From additional info received on 6/17/05, it was reported through an enhanced surveilance program , it was reported that this case occurred in the USA. Reportedly, the pt received his 1st dose of YF-VAX, lot UE126AA, SC in the right arm; a dose of Typhim VI, lot X0481, IM in the left deltoid and his 1st dose of Twinrix, lot AHABA026AA, IM in the right deltoid on 4/6/04 between one and four in the afternoon. Three days later, on 4/9/04, he developed generalized aches and malaise. Seven days after vaccination, he experienced a fever up to 102F. He was seen by a physician on 4/16/04 for a fever of 101.2F, headache, upset stomach and diarrhea. He was dx'd with serum sickness. Reportedly, the pt recovered from this experience. Further info is not anticipated, this case is considered closed.
Age: 48.0
Sex: M
Vaccine: HEPAB, TYP, YF, HEPAB, TYP, YF
Symptoms: Alanine aminotransferase increased, Aspartate aminotransferase increased, Blood chloride decreased, Blood sodium decreased, Diarrhoea
Clinical narrative: This case was received and there were no serious criteria reported. Based upon appropriate medical judgement, this case is considered non-serious. From initial info received on 6/10/04, through an enhanced surveilance program regarding an adverse event occurring in an unknown country, it was reported that a 48 year old male pt received a dose of Yellow Fever vaccine, a dose of Typhoid vaccine and a dose of Twinrix, on 4/6/04. The lot numbers, routes and sites of administration were not reported. Three days later, the pt developed aches and malaise. Approximately 1 week after immunizations, he also developed fevers up to 102F. The pt saw his physician on 4/16/04 for evaluation of headaches, fever and diarrhea. The pt's recovery status was not reported. From additional info received on 6/17/05, it was reported through an enhanced surveilance program , it was reported that this case occurred in the USA. Reportedly, the pt received his 1st dose of YF-VAX, lot UE126AA, SC in the right arm; a dose of Typhim VI, lot X0481, IM in the left deltoid and his 1st dose of Twinrix, lot AHABA026AA, IM in the right deltoid on 4/6/04 between one and four in the afternoon. Three days later, on 4/9/04, he developed generalized aches and malaise. Seven days after vaccination, he experienced a fever up to 102F. He was seen by a physician on 4/16/04 for a fever of 101.2F, headache, upset stomach and diarrhea. He was dx'd with serum sickness. Reportedly, the pt recovered from this experience. Further info is not anticipated, this case is considered closed.
Age: 48.0
Sex: M
Vaccine: HEPAB, TYP, YF, HEPAB, TYP, YF
Symptoms: Headache, Malaise, Neutropenia, Pain, Pyrexia
Clinical narrative: This case was received and there were no serious criteria reported. Based upon appropriate medical judgement, this case is considered non-serious. From initial info received on 6/10/04, through an enhanced surveilance program regarding an adverse event occurring in an unknown country, it was reported that a 48 year old male pt received a dose of Yellow Fever vaccine, a dose of Typhoid vaccine and a dose of Twinrix, on 4/6/04. The lot numbers, routes and sites of administration were not reported. Three days later, the pt developed aches and malaise. Approximately 1 week after immunizations, he also developed fevers up to 102F. The pt saw his physician on 4/16/04 for evaluation of headaches, fever and diarrhea. The pt's recovery status was not reported. From additional info received on 6/17/05, it was reported through an enhanced surveilance program , it was reported that this case occurred in the USA. Reportedly, the pt received his 1st dose of YF-VAX, lot UE126AA, SC in the right arm; a dose of Typhim VI, lot X0481, IM in the left deltoid and his 1st dose of Twinrix, lot AHABA026AA, IM in the right deltoid on 4/6/04 between one and four in the afternoon. Three days later, on 4/9/04, he developed generalized aches and malaise. Seven days after vaccination, he experienced a fever up to 102F. He was seen by a physician on 4/16/04 for a fever of 101.2F, headache, upset stomach and diarrhea. He was dx'd with serum sickness. Reportedly, the pt recovered from this experience. Further info is not anticipated, this case is considered closed.
Age: 48.0
Sex: M
Vaccine: HEPAB, TYP, YF, HEPAB, TYP, YF
Symptoms: Serum sickness, Stomach discomfort
Clinical narrative: This case was received and there were no serious criteria reported. Based upon appropriate medical judgement, this case is considered non-serious. From initial info received on 6/10/04, through an enhanced surveilance program regarding an adverse event occurring in an unknown country, it was reported that a 48 year old male pt received a dose of Yellow Fever vaccine, a dose of Typhoid vaccine and a dose of Twinrix, on 4/6/04. The lot numbers, routes and sites of administration were not reported. Three days later, the pt developed aches and malaise. Approximately 1 week after immunizations, he also developed fevers up to 102F. The pt saw his physician on 4/16/04 for evaluation of headaches, fever and diarrhea. The pt's recovery status was not reported. From additional info received on 6/17/05, it was reported through an enhanced surveilance program , it was reported that this case occurred in the USA. Reportedly, the pt received his 1st dose of YF-VAX, lot UE126AA, SC in the right arm; a dose of Typhim VI, lot X0481, IM in the left deltoid and his 1st dose of Twinrix, lot AHABA026AA, IM in the right deltoid on 4/6/04 between one and four in the afternoon. Three days later, on 4/9/04, he developed generalized aches and malaise. Seven days after vaccination, he experienced a fever up to 102F. He was seen by a physician on 4/16/04 for a fever of 101.2F, headache, upset stomach and diarrhea. He was dx'd with serum sickness. Reportedly, the pt recovered from this experience. Further info is not anticipated, this case is considered closed.
Age: 1.26
Sex: M
Vaccine: HEP
Symptoms: Body temperature increased
Clinical narrative: Elevated temperature to 105 degrees within 24 hours of immunization.
Age: 41.0
Sex: M
Vaccine: YF
Symptoms: Cold sweat, Coma, Dyspnoea, Feeling cold, Gaze palsy
Clinical narrative: From initial information received on 02Dec04 from a healthcare professional regarding an adverse event occurring, it was reported that a 41 yr old male pt received a YF vax vaccination, lot number UE181AA, administered SC in the upper right arm on 02Dec04. At the time of vaccination the pt was also taking Tylenol or Advil. The pt had no illnesses at the time of vaccination, no did he have any pre-existing physician diagnosed allergies, birth defects or medical conditions. His last yellow fever vaccination was eight years ago. Reportedly within 60 seconds of vaccination the pt became pale, cold and clammy, his eyes rolled back and he became unresponsive with labored breathing and general body tremors which lasted approx 45 seconds. Upon treatment at the hospital ER the pt was awake, alert and oriented. Reportedly the pt recovered from this experience. From additional information received on 11Jan05, from a health care professional, the spelling of the reporter's last name was corrected. The reporter also stated that the facility did not have a copy of the pt's ER records. No other information was provided at this time. From additional information received on 18Jan05 through telephone contact with the initial reporter, it was reported that the facility does not have access to the ER records for this pt. The full name and address of the hospital was provided. The reporter stated that the events were unofficially considered to be vasovagal response. From additional information received on 22Feb05 from a health care facility, the emergency dept records were provided. Following admin of YF VAX at 2:00PM on 02Dec04, the pt felt dizzy and lightheaded as he normally does with injections or any type of needle stick. He sat down in a chair, where he subsequently lost consciousness for a brief period of time after his eyes rolled back and he had a small episode of tremulousness. The pt awakened immediately and came back to his normal state very quickly.  The episode lasted approx 30-45 seconds. The pt did not have a period of somnolence following this episode. The pt has had these symptoms before following prior injections. He was taken to the ER where he felt completely normal and refused any further evaluations, as they might have involved drawing blood and he did not want to have another needle stick product yet a similar reaction. The physician from the ER did not think the pt had a seizure. The pt was discharged from the ER with the diagnosis of vasovagal syncope and recovered from the event. Further information is not anticipated, this case is considered closed. Relevant test/laboratory data: The reporter will call with follow up information from ER visit. From additional information received on 22Feb05, vital signs in the ER included a blood pressure of 140/95, temp of 97.6 degrees F, pulse of 102, respirations of 18 and oxygen saturations of 97% on room air.
Age: 41.0
Sex: M
Vaccine: YF
Symptoms: Loss of consciousness, Pallor, Syncope vasovagal, Tremor
Clinical narrative: From initial information received on 02Dec04 from a healthcare professional regarding an adverse event occurring, it was reported that a 41 yr old male pt received a YF vax vaccination, lot number UE181AA, administered SC in the upper right arm on 02Dec04. At the time of vaccination the pt was also taking Tylenol or Advil. The pt had no illnesses at the time of vaccination, no did he have any pre-existing physician diagnosed allergies, birth defects or medical conditions. His last yellow fever vaccination was eight years ago. Reportedly within 60 seconds of vaccination the pt became pale, cold and clammy, his eyes rolled back and he became unresponsive with labored breathing and general body tremors which lasted approx 45 seconds. Upon treatment at the hospital ER the pt was awake, alert and oriented. Reportedly the pt recovered from this experience. From additional information received on 11Jan05, from a health care professional, the spelling of the reporter's last name was corrected. The reporter also stated that the facility did not have a copy of the pt's ER records. No other information was provided at this time. From additional information received on 18Jan05 through telephone contact with the initial reporter, it was reported that the facility does not have access to the ER records for this pt. The full name and address of the hospital was provided. The reporter stated that the events were unofficially considered to be vasovagal response. From additional information received on 22Feb05 from a health care facility, the emergency dept records were provided. Following admin of YF VAX at 2:00PM on 02Dec04, the pt felt dizzy and lightheaded as he normally does with injections or any type of needle stick. He sat down in a chair, where he subsequently lost consciousness for a brief period of time after his eyes rolled back and he had a small episode of tremulousness. The pt awakened immediately and came back to his normal state very quickly.  The episode lasted approx 30-45 seconds. The pt did not have a period of somnolence following this episode. The pt has had these symptoms before following prior injections. He was taken to the ER where he felt completely normal and refused any further evaluations, as they might have involved drawing blood and he did not want to have another needle stick product yet a similar reaction. The physician from the ER did not think the pt had a seizure. The pt was discharged from the ER with the diagnosis of vasovagal syncope and recovered from the event. Further information is not anticipated, this case is considered closed. Relevant test/laboratory data: The reporter will call with follow up information from ER visit. From additional information received on 22Feb05, vital signs in the ER included a blood pressure of 140/95, temp of 97.6 degrees F, pulse of 102, respirations of 18 and oxygen saturations of 97% on room air.
Age: 26.0
Sex: M
Vaccine: IPV, YF
Symptoms: Colitis ulcerative, Diarrhoea haemorrhagic, Large intestine perforation, Spleen disorder
Clinical narrative: From initial info received on 1/5/05, through an enhanced surveilance program, it was reported that a 26 year old male pt, who was in the military, received a dose of Yellow Fever vaccine on 10/16/02. He subsequently received a dose of Poliomyelitis vaccine inactivated and a dose of Hep-A vaccine on 10/21/02. The mfrs, lot numbers, routes and sites of administration were not reported for any of the vaccines. Three to seven days after receiving the Yellow Fever vaccine, the pt developed blood diarrhea. He had a colonoscopy, which revealed multiple colonic perforations in the left colon and splenic flexure. He had a subtotal colectomy with ileostomy on 12/19/02. A pathology report indicated 2 sections of markedly active. In 2004, the pt had an ileoanal J-pouch procedure with loop ileostomy and a subsequent proctectomy and ileoanal J-pouch procedure. He was cleared for active duty without restriction and is currently being seen at the military's vaccine healthcare center. It was not reported whether the pt recovered from these events. From additional info received on 1/13/05, the age of the pt was 26 at the time of the event onset. An additional dx of a spleen disorder was provided as well as lab values. The name and address of the initial reporter was also provided. Comments: Medical assessment: Ulcerative colitis is a chronic inflammatory disorder and  the cause of this evolutive bowel disease has not yet been elucidated. Contributing factors including genetic predisposition, infections and psychosocial factors, have been evoked. This case remains difficult to assess at this time, however, the event was reported in a 26 year old male pt, while ulcerative colitis is predominantly a disease of the young and most cases are diagnosed before age 30.
Age: 27.0
Sex: M
Vaccine: HEP, MEN, YF, HEP, MEN, YF
Symptoms: Diarrhoea, Hyperhidrosis, Vomiting
Clinical narrative: From initial info received on 8/5/04 from an RN regarding an adverse event occurring in the USA, it was reported that a 26 year old male pt received a dose of Menomune A/C/Y/W-135, lot UE123AA, administered IM in the right upper arm; a dose of YF-VAX, lot UE080AA, SC in the left upper arm and a second dose of Hepatitis B vaccine, lot 0628N, IM in the left deltoid on 8/3/04 at 11:00 AM. Twelve hours later, at 23:00 PM on 8/3/04, the pt developed vomiting and diarrhea, which stopped on 8/4/04. The pt also experienced sweating on 8/4/04 and 8/5/04. Reportedly, the pt recovered from these events. From additional information received on 11/18/04 from the initial reporter, it was reported that this case was received and there is no additional info at this time. No further info is anticipated, this case is considered closed.
Age: 23.0
Sex: F
Vaccine: TD, YF, TD, YF, TD, YF
Symptoms: Abdominal pain, Diarrhoea, Fatigue, Influenza like illness, Lethargy
Clinical narrative: From initial info received on 9/2/04 from a health care professional, it was reported that a 22 year old female pt received her 6th dose of TD ADS ADULT vaccine, lot U1282AA, IM in  an unspecified site and her 1st dose of YF-VAX vaccine, lot UE180AA, SC in an unspecified site at 13:00 PM on 8/30/04. Two days later, on 9/1/04, the pt developed flu-like symptoms, became lethargic and her left axilla lymph nodes became enlarged. On 9/2/04, the pt was examined by a physician and no enlargement of lymph nodes were noted. The pt recovery status is currently unknown. From additional info received on 9/28/04 from a health care professional, it was reported the the pt's flu-like symptoms consisted of diarrhea, stomach cramping and fatigue. She also had arm aches. It was not reported whether the pt recovered from these events.
Age: 23.0
Sex: F
Vaccine: TD, YF, TD, YF, TD, YF
Symptoms: Lymphadenopathy, Pain
Clinical narrative: From initial info received on 9/2/04 from a health care professional, it was reported that a 22 year old female pt received her 6th dose of TD ADS ADULT vaccine, lot U1282AA, IM in  an unspecified site and her 1st dose of YF-VAX vaccine, lot UE180AA, SC in an unspecified site at 13:00 PM on 8/30/04. Two days later, on 9/1/04, the pt developed flu-like symptoms, became lethargic and her left axilla lymph nodes became enlarged. On 9/2/04, the pt was examined by a physician and no enlargement of lymph nodes were noted. The pt recovery status is currently unknown. From additional info received on 9/28/04 from a health care professional, it was reported the the pt's flu-like symptoms consisted of diarrhea, stomach cramping and fatigue. She also had arm aches. It was not reported whether the pt recovered from these events.
Age: 23.0
Sex: F
Vaccine: TD, YF, TD, YF, TD, YF
Symptoms: Influenza like illness, Lethargy, Lymphadenopathy
Clinical narrative: From initial info received on 9/2/04 from a health care professional, it was reported that a 22 year old female pt received her 6th dose of TD ADS ADULT vaccine, lot U1282AA, IM in  an unspecified site and her 1st dose of YF-VAX vaccine, lot UE180AA, SC in an unspecified site at 13:00 PM on 8/30/04. Two days later, on 9/1/04, the pt developed flu-like symptoms, became lethargic and her left axilla lymph nodes became enlarged. On 9/2/04, the pt was examined by a physician and no enlargement of lymph nodes were noted. The pt recovery status is currently unknown. From additional info received on 9/28/04 from a health care professional, it was reported the the pt's flu-like symptoms consisted of diarrhea, stomach cramping and fatigue. She also had arm aches. It was not reported whether the pt recovered from these events.
Age: 60.0
Sex: M
Vaccine: YF, YF
Symptoms: Anaemia, Bacterial infection, Dehydration, Electrolyte imbalance, Hepatitis
Clinical narrative: From initial information received on 31Jan05 regarding an adverse event occurring, it was reported that a 60 yr old male pt received a dose of YF Vax, lot number UE181AA, with the expiration date of 02Sep05 administered on 01Nov04 in preparation for travel. The route and site of administration were not reported. An unspecified amount of time later, after departure for his trip, the pt started to developed symptoms. Still awaiting further information from hospital medical records, but reportedly the report indicated sepsis and multiple electrolyte abnormalities. The pt was admitted to the hospital five days after vaccination for a duration of ten days and was placed under aggressive supportive care with fluids. Tests for typhoid fever, rocky mountain spotted fever, CMV and EEV were all negative. The pt was discharged with the diagnosis of sepsis syndrome, anemia, hypotension, respiratory insufficiency, pancytopenia and renal insufficiency. Per the reporter, the pt has apparently fully recovered. Hospital chart and laboratory data is to be requested.
Age: 60.0
Sex: M
Vaccine: YF, YF
Symptoms: Hypotension, Influenza like illness, Injection site reaction, Metabolic acidosis, Pancytopenia
Clinical narrative: From initial information received on 31Jan05 regarding an adverse event occurring, it was reported that a 60 yr old male pt received a dose of YF Vax, lot number UE181AA, with the expiration date of 02Sep05 administered on 01Nov04 in preparation for travel. The route and site of administration were not reported. An unspecified amount of time later, after departure for his trip, the pt started to developed symptoms. Still awaiting further information from hospital medical records, but reportedly the report indicated sepsis and multiple electrolyte abnormalities. The pt was admitted to the hospital five days after vaccination for a duration of ten days and was placed under aggressive supportive care with fluids. Tests for typhoid fever, rocky mountain spotted fever, CMV and EEV were all negative. The pt was discharged with the diagnosis of sepsis syndrome, anemia, hypotension, respiratory insufficiency, pancytopenia and renal insufficiency. Per the reporter, the pt has apparently fully recovered. Hospital chart and laboratory data is to be requested.
Age: 60.0
Sex: M
Vaccine: YF, YF
Symptoms: Renal failure, Respiratory failure, Rickets, Sepsis, Viral infection
Clinical narrative: From initial information received on 31Jan05 regarding an adverse event occurring, it was reported that a 60 yr old male pt received a dose of YF Vax, lot number UE181AA, with the expiration date of 02Sep05 administered on 01Nov04 in preparation for travel. The route and site of administration were not reported. An unspecified amount of time later, after departure for his trip, the pt started to developed symptoms. Still awaiting further information from hospital medical records, but reportedly the report indicated sepsis and multiple electrolyte abnormalities. The pt was admitted to the hospital five days after vaccination for a duration of ten days and was placed under aggressive supportive care with fluids. Tests for typhoid fever, rocky mountain spotted fever, CMV and EEV were all negative. The pt was discharged with the diagnosis of sepsis syndrome, anemia, hypotension, respiratory insufficiency, pancytopenia and renal insufficiency. Per the reporter, the pt has apparently fully recovered. Hospital chart and laboratory data is to be requested.
Age: 60.0
Sex: M
Vaccine: YF, YF
Symptoms: Anaemia, Electrolyte imbalance, Hypotension, Pancytopenia, Renal failure
Clinical narrative: From initial information received on 31Jan05 regarding an adverse event occurring, it was reported that a 60 yr old male pt received a dose of YF Vax, lot number UE181AA, with the expiration date of 02Sep05 administered on 01Nov04 in preparation for travel. The route and site of administration were not reported. An unspecified amount of time later, after departure for his trip, the pt started to developed symptoms. Still awaiting further information from hospital medical records, but reportedly the report indicated sepsis and multiple electrolyte abnormalities. The pt was admitted to the hospital five days after vaccination for a duration of ten days and was placed under aggressive supportive care with fluids. Tests for typhoid fever, rocky mountain spotted fever, CMV and EEV were all negative. The pt was discharged with the diagnosis of sepsis syndrome, anemia, hypotension, respiratory insufficiency, pancytopenia and renal insufficiency. Per the reporter, the pt has apparently fully recovered. Hospital chart and laboratory data is to be requested.
Age: 60.0
Sex: M
Vaccine: YF, YF
Symptoms: Respiratory failure, Sepsis
Clinical narrative: From initial information received on 31Jan05 regarding an adverse event occurring, it was reported that a 60 yr old male pt received a dose of YF Vax, lot number UE181AA, with the expiration date of 02Sep05 administered on 01Nov04 in preparation for travel. The route and site of administration were not reported. An unspecified amount of time later, after departure for his trip, the pt started to developed symptoms. Still awaiting further information from hospital medical records, but reportedly the report indicated sepsis and multiple electrolyte abnormalities. The pt was admitted to the hospital five days after vaccination for a duration of ten days and was placed under aggressive supportive care with fluids. Tests for typhoid fever, rocky mountain spotted fever, CMV and EEV were all negative. The pt was discharged with the diagnosis of sepsis syndrome, anemia, hypotension, respiratory insufficiency, pancytopenia and renal insufficiency. Per the reporter, the pt has apparently fully recovered. Hospital chart and laboratory data is to be requested.
Age: 33.0
Sex: F
Vaccine: YF, YF
Symptoms: Injection site rash, Rash pruritic
Clinical narrative: From initial info received on 2/3/05 and 2/4/05 from a health care professional regarding an adverse event occurring in the USA, it was reported that a 33 year old female pt received a dose of YF-VAX, lot UE352AA, administered SC in the left deltoid on 1/28/05. Two days later, on 1/30/05, the pt developed a maculo-papular rash at the injection site. The rash spread to her trunk and was pruritic. The pt self-medicated with antihistamines and recovered from these events.
Age: 33.0
Sex: F
Vaccine: YF, YF
Symptoms: Injection site reaction, Pruritus, Rash maculo-papular
Clinical narrative: From initial info received on 2/3/05 and 2/4/05 from a health care professional regarding an adverse event occurring in the USA, it was reported that a 33 year old female pt received a dose of YF-VAX, lot UE352AA, administered SC in the left deltoid on 1/28/05. Two days later, on 1/30/05, the pt developed a maculo-papular rash at the injection site. The rash spread to her trunk and was pruritic. The pt self-medicated with antihistamines and recovered from these events.
Age: 29.0
Sex: F
Vaccine: IPV, YF, IPV, YF, IPV, YF
Symptoms: Headache, Hyperhidrosis, Laboratory test abnormal, Malaise, Mouth ulceration
Clinical narrative: From initial info received on 2/4/05 from a health care professional regarding an adverse event occurring in the USA, it was reported that a 29 year old female pt received a dose of YF-VAX as well as a dose of IPOL, administered on 1/28/05. The lot numbers, routes and sites of administration were not reported. The following day, the pt developed a fever of 103F, chills, sweats, nausea and vomiting as well as swollen gums and mouth ulceration. She was seen in the ER and by an infectious disease specialist. Reportedly, the pt received a dose of Typhim VI and Hep-A vaccine within 4 weeks prior to immunization on 1/28/05, but exact dates were not provided. It was not reported whether she developed any reactions after receiving these injections. Per the reporter, the pt has not recovered from these events.
Age: 29.0
Sex: F
Vaccine: IPV, YF, IPV, YF, IPV, YF
Symptoms: Nausea, Pharyngolaryngeal pain, Pyrexia, Vomiting
Clinical narrative: From initial info received on 2/4/05 from a health care professional regarding an adverse event occurring in the USA, it was reported that a 29 year old female pt received a dose of YF-VAX as well as a dose of IPOL, administered on 1/28/05. The lot numbers, routes and sites of administration were not reported. The following day, the pt developed a fever of 103F, chills, sweats, nausea and vomiting as well as swollen gums and mouth ulceration. She was seen in the ER and by an infectious disease specialist. Reportedly, the pt received a dose of Typhim VI and Hep-A vaccine within 4 weeks prior to immunization on 1/28/05, but exact dates were not provided. It was not reported whether she developed any reactions after receiving these injections. Per the reporter, the pt has not recovered from these events.
Age: 29.0
Sex: F
Vaccine: IPV, YF, IPV, YF, IPV, YF
Symptoms: Chills, Face oedema, Hyperhidrosis, Mouth ulceration, Nausea
Clinical narrative: From initial info received on 2/4/05 from a health care professional regarding an adverse event occurring in the USA, it was reported that a 29 year old female pt received a dose of YF-VAX as well as a dose of IPOL, administered on 1/28/05. The lot numbers, routes and sites of administration were not reported. The following day, the pt developed a fever of 103F, chills, sweats, nausea and vomiting as well as swollen gums and mouth ulceration. She was seen in the ER and by an infectious disease specialist. Reportedly, the pt received a dose of Typhim VI and Hep-A vaccine within 4 weeks prior to immunization on 1/28/05, but exact dates were not provided. It was not reported whether she developed any reactions after receiving these injections. Per the reporter, the pt has not recovered from these events.
Age: 29.0
Sex: F
Vaccine: IPV, YF, IPV, YF, IPV, YF
Symptoms: Pyrexia, Vomiting
Clinical narrative: From initial info received on 2/4/05 from a health care professional regarding an adverse event occurring in the USA, it was reported that a 29 year old female pt received a dose of YF-VAX as well as a dose of IPOL, administered on 1/28/05. The lot numbers, routes and sites of administration were not reported. The following day, the pt developed a fever of 103F, chills, sweats, nausea and vomiting as well as swollen gums and mouth ulceration. She was seen in the ER and by an infectious disease specialist. Reportedly, the pt received a dose of Typhim VI and Hep-A vaccine within 4 weeks prior to immunization on 1/28/05, but exact dates were not provided. It was not reported whether she developed any reactions after receiving these injections. Per the reporter, the pt has not recovered from these events.
Age: 29.0
Sex: F
Vaccine: IPV, YF, IPV, YF, IPV, YF
Symptoms: Chills, Hyperhidrosis, Mouth ulceration, Nausea, Oedema
Clinical narrative: From initial info received on 2/4/05 from a health care professional regarding an adverse event occurring in the USA, it was reported that a 29 year old female pt received a dose of YF-VAX as well as a dose of IPOL, administered on 1/28/05. The lot numbers, routes and sites of administration were not reported. The following day, the pt developed a fever of 103F, chills, sweats, nausea and vomiting as well as swollen gums and mouth ulceration. She was seen in the ER and by an infectious disease specialist. Reportedly, the pt received a dose of Typhim VI and Hep-A vaccine within 4 weeks prior to immunization on 1/28/05, but exact dates were not provided. It was not reported whether she developed any reactions after receiving these injections. Per the reporter, the pt has not recovered from these events.
Age: 13.0
Sex: M
Vaccine: YF, YF
Symptoms: Dyspnoea
Clinical narrative: From initial information received on 09May05 from a health care professional regarding an adverse event occurring, it was reported that a 13 yr old male pt received a dose of YF Vax, lot UE500AA, admin SC in the left arm on 06May05 at 11:45AM. At 2:00PM on 06May05, the pt experienced shortness of breath. He visited the ER and was treated with Benadryl, epinephrine and Solumedrol. He was admitted for observation at another hospital due to the unavailability of beds at the first hospital. At the time of this report it is unk if the pt recovered from these events.
Age: 21.0
Sex: F
Vaccine: HEPA, YF, HEPA, YF
Symptoms: Chills, Hyperhidrosis, Pain, Pharyngolaryngeal pain, Pyrexia
Clinical narrative: From initial information received on 13May05 from a RN regarding an adverse event occurring, it was reported that a 21 yr old female pt received a dose of YF Vax, lot number UE498AA, administered SC in the left upper arm as well as a dose of Hep A vaccine, lot number AHAVB0032BA, admin IM in the left deltoid on 11May05. An unspecified amount of time later that day, the pt developed pain in her legs, chills, a sore throat and felt very exhausted. Her temp varied between 101 and 102.5 degrees F. The pt went to the ER at 1:00AM on 12May05. A strep screen was negative. The pt was treated with morphine, ibuprofen and IV fluids. Reportedly, the pt did not recover from these events.
Age: 21.0
Sex: F
Vaccine: HEPA, YF, HEPA, YF
Symptoms: Chills, Fatigue, Injection site pain, Pharyngolaryngeal pain, Pyrexia
Clinical narrative: From initial information received on 13May05 from a RN regarding an adverse event occurring, it was reported that a 21 yr old female pt received a dose of YF Vax, lot number UE498AA, administered SC in the left upper arm as well as a dose of Hep A vaccine, lot number AHAVB0032BA, admin IM in the left deltoid on 11May05. An unspecified amount of time later that day, the pt developed pain in her legs, chills, a sore throat and felt very exhausted. Her temp varied between 101 and 102.5 degrees F. The pt went to the ER at 1:00AM on 12May05. A strep screen was negative. The pt was treated with morphine, ibuprofen and IV fluids. Reportedly, the pt did not recover from these events.
Age: 18.0
Sex: M
Vaccine: MNQ, MNQ, MNQ
Symptoms: Abnormal behaviour, CSF test abnormal, Diarrhoea, Fatigue, Headache
Clinical narrative: Left hemiparesis with numbness. Left facial asymmetry with slurred speech. Headache. Elevated protein in CSF (117). No meningeal signs, fever, or muscle rigidity. Follow-up: This pt was given the vaccine that led to the filing of the VAERS report @ Health Department. The have filled out the initial form and we filled out the rest of the information as far as treatment and extent of adverse reaction because we followed him in the hospital. All original info on vaccine is at Health department.
Age: 18.0
Sex: M
Vaccine: MNQ, MNQ, MNQ
Symptoms: Hypoaesthesia, Laboratory test abnormal, Myasthenic syndrome, Nausea, Vomiting
Clinical narrative: Left hemiparesis with numbness. Left facial asymmetry with slurred speech. Headache. Elevated protein in CSF (117). No meningeal signs, fever, or muscle rigidity. Follow-up: This pt was given the vaccine that led to the filing of the VAERS report @ Health Department. The have filled out the initial form and we filled out the rest of the information as far as treatment and extent of adverse reaction because we followed him in the hospital. All original info on vaccine is at Health department.
Age: 18.0
Sex: M
Vaccine: MNQ, MNQ, MNQ
Symptoms: White blood cell count increased
Clinical narrative: Left hemiparesis with numbness. Left facial asymmetry with slurred speech. Headache. Elevated protein in CSF (117). No meningeal signs, fever, or muscle rigidity. Follow-up: This pt was given the vaccine that led to the filing of the VAERS report @ Health Department. The have filled out the initial form and we filled out the rest of the information as far as treatment and extent of adverse reaction because we followed him in the hospital. All original info on vaccine is at Health department.
Age: 18.0
Sex: M
Vaccine: MNQ, MNQ, MNQ
Symptoms: CSF protein increased, Dysarthria, Head deformity, Headache, Hemiparesis
Clinical narrative: Left hemiparesis with numbness. Left facial asymmetry with slurred speech. Headache. Elevated protein in CSF (117). No meningeal signs, fever, or muscle rigidity. Follow-up: This pt was given the vaccine that led to the filing of the VAERS report @ Health Department. The have filled out the initial form and we filled out the rest of the information as far as treatment and extent of adverse reaction because we followed him in the hospital. All original info on vaccine is at Health department.
Age: 18.0
Sex: M
Vaccine: MNQ, MNQ, MNQ
Symptoms: Hypoaesthesia, White blood cell count normal
Clinical narrative: Left hemiparesis with numbness. Left facial asymmetry with slurred speech. Headache. Elevated protein in CSF (117). No meningeal signs, fever, or muscle rigidity. Follow-up: This pt was given the vaccine that led to the filing of the VAERS report @ Health Department. The have filled out the initial form and we filled out the rest of the information as far as treatment and extent of adverse reaction because we followed him in the hospital. All original info on vaccine is at Health department.
Age: 18.0
Sex: M
Vaccine: MNQ, MNQ, MNQ
Symptoms: Diarrhoea, Fatigue, Headache, Hypoaesthesia, Nausea
Clinical narrative: Left hemiparesis with numbness. Left facial asymmetry with slurred speech. Headache. Elevated protein in CSF (117). No meningeal signs, fever, or muscle rigidity. Follow-up: This pt was given the vaccine that led to the filing of the VAERS report @ Health Department. The have filled out the initial form and we filled out the rest of the information as far as treatment and extent of adverse reaction because we followed him in the hospital. All original info on vaccine is at Health department.
Age: 18.0
Sex: M
Vaccine: MNQ, MNQ, MNQ
Symptoms: Vomiting
Clinical narrative: Left hemiparesis with numbness. Left facial asymmetry with slurred speech. Headache. Elevated protein in CSF (117). No meningeal signs, fever, or muscle rigidity. Follow-up: This pt was given the vaccine that led to the filing of the VAERS report @ Health Department. The have filled out the initial form and we filled out the rest of the information as far as treatment and extent of adverse reaction because we followed him in the hospital. All original info on vaccine is at Health department.
Age: 0.09
Sex: M
Vaccine: HEP
Symptoms: Autism
Clinical narrative: This case was reported by a consumer and described the occurrence of autism in a 8 year old male subject who was vaccinated with hepatitis B vaccine recombinant for prophylaxis. The reporter is the father of the subject. A physician or other health care professional has not verified this report. Medical history included gluten free diet. On 5/17/97, the subject received the second dose of Engerix B (lot # ENG2118A2). Approximately eight years after vaccination with Engerix B, on an unspecified date on or after 4/14/05, the subject was diagnosed with autism. The autism was ongoing at the time of initial reporting, 7/13/05. Comment: autism was assessed as medically serious (OMIC).
Age: 35.0
Sex: M
Vaccine: FLU3
Symptoms: Asthma, Leukocytosis, Pain, Swelling, Urticaria
Clinical narrative: Subject noted forehead swelling on 06/29/2005, the day following vaccination.  On 07/01/2005 he noted painful hives on both legs and on 07/02/2005, he developed bilateral ankle swelling.  On 07/06/2005, he sought medical attention at the local hospital where he received intramuscularly and by mouth Benadryl.  Information recieved from discharge summary states dyspnea.